phoneCall Now for a Free Case Evaluation - 800-611-7080
Seedol.com > News > John

New Complications in the Vaginal Mesh Lawsuit

November 14, 2012 by
Vaginal Mesh Lawsuit News Update

Vaginal Mesh Lawsuit News Update

11/14/2012 Manufacturers of Vaginal Mesh Products may face new Vaginal Mesh Lawsuit cases from States. Although over two thousand Vaginal Mesh Lawsuits have already been filed by women who suffered injuries as a result of vaginal mesh products, cases bu Government entities add a new twist to the situation. If you were injured by a Vaginal Mesh Product and have yet to  consult with legal counsel, please follow this link  to arrange a free consultation with a Vaginal Mesh Lawyer : File a Vaginal Mesh Lawsuit.

Vaginal Mesh Lawsuits filed by States

It is not unusual for States and even the Federal Government to bring their own lawsuits in pharmaceutical and Medical device cases. The facts that lead to individuals filing cases like Vaginal Mesh Lawsuits often , in part or in whole , are based on issues that involve regulatory violations or violations of law. When a Medical Device manufacturer or a Pharmaceutical Company violates State and or Federal Regulations, these Government entities can bring lawsuits and criminal charges against the manufacturer. The cost of settling the cases brought by Government agencies can often exceed the cost of settling the lawsuits brought by the individuals who were injured by the products.

Ramifications of Vaginal Mesh Lawsuit cases filed by Government Entities

In some cases, a Government entity might bring its case against a manufacturer after lawsuits by individuals are settled. In other cases the Government’s action may precede any lawsuits brought by individuals. In the Vaginal Mesh Lawsuit, it appears that at least some Government entities may bring cases against some manufacturers of Vaginal Mesh Products during while the Vaginal Mesh Lawsuits by individuals are ongoing. The discoveries made in any government investigations could impact the Vaginal Mesh Lawsuits filed by individuals in a positive manner.

The Vaginal Mesh Lawsuit has a lengthy future

The Vaginal Mesh Lawsuit is likely to be going for some time. The possible involvement of Government Entities filing there on cases could serve to lengthen the life span of the case. In addition, the fact that not all women who have been injured have filed a vaginal mesh lawsuit contributes to the likelihood of a lengthy future for the case. Lastly, many women currently have vaginal  mesh implants that have yet to become problematic but may at any time. The pool of potential Vaginal Mesh Lawsuit plaintiffs filing future cases is not quantifiable at this point in time.

For more information relevant to the Vaginal Mesh Lawsuit, refer to the website of the FDA.

Filed Under: Breaking News, Featured, Vaginal Mesh Lawsuit Tagged With:

Chantix Lawsuit News

September 18, 2012 by
Chantix Lawsuit News

Chantix Lawsuit News

09/18/2012 Chantix Lawsuit News:  Recent information released by the FDA has given rise to controversy over whether the manufacturer of Chantix was forth coming with information that may have given the FDA a better picture of the extent of the link between Chantix and Suicide. This could prove to have an impact on future Chantix Lawsuit cases involving Chantix and Suicide.

Currently Chantix includes a warning on its label regarding suicidal thoughts however,  there has not been enough data provided regarding the actual number of suicides directly linked to Chantix for the public to make a determination as to the risk of actually committing suicide while taking Chantix. A warning about increased suicidal thoughts falls far short of having the impact of actual data on the number of actual suicides linked to Chantix.

If it turns out that the maker of Chantix has withheld information in its possession regarding the link between Chantix and the actual rate of suicides among Chantix users, this omission could be used against them in future Chantix Lawsuits.

Our research department could not find any statistical information regarding the rate of actual suicides among Chantix users. We reviewed the FDA adverse event reporting data and numerous adverse events have been reported however,  due to the fact that the public is largely unaware that the FDA Adverse event reporting system exists, it cannot be used to draw any comprehensive conclusions.

Chantix gained market approval for use as product to help with smoking cessation in 2006. The link between Chantix and Suicidal thoughts has been part of the warning label for Chantix for some time now however, despite the fact that it is well known that there is a link between Chantix and Suicidal thoughts, there seems to be very little reliable data on the number of actual suicides linked to Chantix.

If your loved one committed suicide while taking Chantix, you may be eligible to file a Chantix Lawsuit. Please contact (800)611-7080 for more information.

Filed Under: Breaking News, Featured, Lawsuit News Tagged With: , ,

Pradaxa Lawsuit MDL News

September 17, 2012 by
Pradaxa Lawsuit MDL News

Pradaxa Lawsuit MDL News

09/17/2012 The Pradaxa Lawsuit Multidistrict Litigation has been established in the courtroom of  Judge David Herdon in Illinois. Judge Herdon is also currently also presiding over the Yaz/ Yazmin Multi District litigation which is much further along in the MDL Process than the Pradaxa Lawsuit Multi District Litigation.

Boehringer Ingelheim to date attempts by Boehringer Ingelheim, the maker of Pradaxa to have the Pradaxa Lawsuit case dismissed have failed and the court  has allowed the case to proceed.  The court has indicated that trial  dates for the existing Pradaxa Lawsuit cases could be set as early as eighteen months from now.

For those unfamiliar with a Multidistrict litigation, or  “MDL”,  the Pradaxa Multi District Litigation  is somewhat like a Pradaxa Class Action Lawsuit. In fact, the Pradaxa MDL is often referred to my the public as the Pradaxa Class Action Lawsuit. Although both an MDL and a Class Action Lawsuit consolidate similar cases against a defendant or group  of defendants into a single court room under the Jurisdiction of a single Judge or Panel of Judges, an MDL and a Class Action are not identical. In the Pradaxa MDL each individual Pradaxa Lawsuit remains a separate case while in a Pradaxa Class Action Lawsuit all cases would be heard as a single case and a single judgment or settlement would be reached that included all claims being considered in the Class Action Lawsuit.

So far the Pradaxa Multidistrict Litigation has had over one hundred cases admitted for inclusion. This number  is likely to increase  dramatically over the next  year.  The maker of  Pradaxa admits to having knowledge of far more than 100 Pradaxa related deaths and not every Pradaxa Lawsuit claim will involve a death.  Many Pradaxa Lawsuit claims are likely to be based on bleeding related injuries that did not result in death however did result in significant injury to the Pradaxa user.

For more information or to arrange a free consultation with a Pradaxa Lawyer, contact  the Best Legal Source Pradaxa Hotline at (800) 611-7080

Filed Under: Pradaxa Lawsuit Tagged With:

Yaz Lawsuit New Kidney Stone Information

September 12, 2012 by
Yaz Lawsuit New Kidney Stone Information

Yaz Lawsuit New Kidney Stone Information

09-12-2012 – Yaz Lawsuit New Information on kidney stone related issues.  A Yaz Lawsuit was filed by a California Woman alleging that Yaz was the underlying cause of her developing kidney stones. To the best of our knowledge this is the first Yaz Lawsuit or Yasmin Lawsuit which claims that either of these block buster birth control products causes kidney stones. To date the medical issues that have been at the center of both the Yaz Lawsuit and Yasmin Lawsuit have centered around blood clot related issues and to a lesser extent Gallbladder issues.

Whether or not the California Woman and her lawyer will chose to add their case to the existing Yaz/Yasmin Multi District Litigation in Illinois has yet to be made known. The Current MDL is often referred to by the public as the Yaz Class Action Lawsuit or Yasmin Class Action Lawsuit, although a Multi District litigation is not exactly the same thing as a Class Action Lawsuit although they do have many similarities.

Like with the Yaz Lawsuit Claims stemming from Blood Clot related issues as well as Gallbladder issues, any claims regarding a link between Yaz or Yasmin and Kidney stones will have to be supported by medical and scientific evidence.

Kidney Stones may not be the last medical issue that will be alleged to be linked to Yaz or Yasmin. Any medication that causes blood clots or effects the body’s  ability to correctly coagulate blood could lead to any number of medical issues. Some of these issues may occur quickly, like a pulmonary embolism, a stroke or a DVT caused by the formation of a blood clot. Other medical issues related to a change in a person’s clotting factors could take much longer to develop. Blood chemistry is extremely complex and can affect every single organ in the body in one fashion or another.

If the California Plaintiff is able to establish a link between her development of Kidney Stones and Yaz or Yasmin, Bayer’s problems with these drugs could be far from over.

If you or a family member believe you were injured by Yaz or Yasmin please do not hesitate to contact our Yaz Lawsuit Hotline at (800) 611-7080 to arrange a free legal consultation.

Filed Under: Yasmin Lawsuit, Yaz Lawsuit Tagged With: , , ,

Pradaxa Lawsuit Details Manufacturer Marketing Spending

September 3, 2012 by
Pradaxa Lawsuit Details Marketing Spending

Pradaxa Lawsuit Details Marketing Spending

09/03/2012 – A New Pradaxa Lawsuit gives details on Manufacturers Marketing Spending. The Pradaxa Lawsuit filed in Arkansas provided more detail than any of our investigators have previously seen regarding the amount the manufacturer of Pradaxa spent in a single year promoting marketing claims that Pradaxa was superior to other similar drugs such as Warfarin.

The Arkansas Pradaxa Lawsuit alleges that the manufacturer spent in excess of 500 million dollars promoting Pradaxa in just 12 months.  This may have a strong impact on a jury or a court given that most Pradaxa Lawsuit cases allege false and misleading advertising as one of their claims against the manufacturer of Pradaxa.

The Pradaxa Lawsuit filings in the Arkansas case alleges that the maker of Pradaxa spent 67 million dollars in 2010 promoting Pradaxa even though Pradaxa was did not approve FDA marketing clearance until Oct of 2010. The suit further alleges that the manufacturer of Pradaxa spent another 464,000,000.00 in a 12 month period on “detailing sessions” and other marketing  to promote the drug to prescribers.

Detailing Sessions can include simple visits to doctors’ offices by drug sales representatives  however,  it is also common for drug manufacturers to hold elaborate “educational events” for doctors and other prescribers which include perks. These events are often held at resorts and other high end facilities.  No allegations of wrong doing were made in the suit with regard to any incentives or perks provided to prescribers in the detailing process.  Our explanation of  “detailing sessions”  is given as the general public is not familiar with the  meaning of “Detailing Session” which is in effect no more than code word for marketing often used by the Pharmaceutical Industry.

An irony that comes to light with regard to the amount of money the maker of Pradaxa allegedly spent on marketing in a single year is the fact that pharmaceutical manufacturers constantly complain about attorneys that advertise to the public about pharmaceutical products that are known to be defective.  Some drug manufacturers and medical device makers have went so far as to file suit against attorneys who ran ads educating the public regarding their defective products.   We find it ironic that one drug manufacturer is alleged to have spent in excess of $500,000,000.00 dollars in 12 months to promote a drug that they now admit to knowing has caused the death of a large number of people.  Although we have no official figures, we are very familiar with the advertising budgets of lawyers and law firms and speculated that all of the advertising spent by every law firm in the nation that educates the public on defective drugs would not equal what the manufacturer of Pradaxa spent on just one drug.

If you or a family member was harmed by Pradaxa please feel free to contact the toll free hotline set up by Best Legal Source (800) 611-7080 to arrange a free consultation with an attorney accepting clients for the Pradaxa Lawsuit.

Filed Under: Pradaxa Lawsuit Tagged With:

Pradaxa Lawsuit Information

August 10, 2012 by
Pradaxa Lawsuit Information

Pradaxa Lawsuit Information

08/10/2012 Pradaxa Lawsuit information: Pradaxa Lawsuit claims have been filed for the past 6 months against Boehringer Ingelheim, the maker of Pradaxa. Anyone who experienced uncontrollable bleeding while taking this medication, is encouraged to speak with a Pradaxa Lawyer about the potential of a Pradaxa Lawsuit. Contact Best Legal Source for access to a Pradaxa Lawsuit attorney.

1-800-611-7080

 

Information for Potential Pradaxa Lawsuit Plaintiffs

Those looking to enter the Pradaxa Lawsuit should be aware of the facts concerning this case. A Pradaxa Lawsuit will assist you in obtaining compensation for expenses related to taking Pradaxa. Those qualifying for a Pradaxa Lawsuit claim must meet certain criteria outlined by a Pradaxa Lawsuit attorney. We can arrange a free consultation for you with an attorney who can discuss your potential for a Pradaxa Lawsuit. To qualify for a consultation, you must have experienced a life-threatening or excessive bleeding event while taking Pradaxa. If this scenario is familiar, call Best Legal Source.

1-800-611-7080

 

Expenses Related to Pradaxa Lawsuit

The expense of Pradaxa Lawsuits should not be a concern for those victims of this drug. A Pradaxa Lawsuit attorney will assist you by taking on your case at no upfront cost. They will only be paid upon the completion of a successful Pradaxa Lawsuit and even then—their fees are taken from the winnings and not from your pocket. You are not undertaking any financial risk when you file a Pradaxa Lawsuit.

Background History Leading to Pradaxa Lawsuit Filings

Pradaxa is an anticoagulant drug and these particular drugs have long been associated with bleeding events. The reason victims file Pradaxa Lawsuit claims is because the bleeds are excessive (even life-threatening) and there is no reversal agent for the bleeding. Among the many charges of Pradaxa Lawsuit documents, the Pradaxa Lawsuit attorneys often mention that the defendant did not properly warn consumers of the risk even though they had knowledge of it.

1-800-611-7080

 

Pradaxa Lawsuit and FDA Response

The FDA has alerted the public about the possible increased risk of excessive bleeding while taking Pradaxa. It is the manufacturer’s duty to adequately warn physicians and consumers of all risks associated with taking their product. Many Pradaxa Lawsuit documents claim that the Pradaxa Lawsuit plaintiff was not properly warned about the severity of the bleeds and the lack of a reversal agent. The U.S. Food and Drug Administration website is a good source for future health information regarding Pradaxa. Visit us for the latest Pradaxa Lawsuit News.

Best Legal Source Implications Regarding Pradaxa Lawsuit Terminology

Best Legal Source does not mean to imply that we are the makers of Pradaxa by using the terms Pradaxa Lawsuit and Pradaxa Lawsuit attorney. We simply are describing the legal action taken for those devastatingly harmed by this medication. A Pradaxa Lawsuit attorney is a professional attorney well-versed in pharmaceutical litigation.

Contact Us for Your Pradaxa Lawsuit Attorney Search

Best Legal Source can be reached at (800) 611-7080 to connect you with a Pradaxa Lawsuit attorney. Time is very important for the successful chances of your case. Please take action today!

1-800-611-7080

 

Read following example from a Pradaxa Lawsuit in East St. Louis

The following is from the East St. Louis Division and includes excerpts from an actual Pradaxa Lawsuit. The content in the form of headings and notes was written by Best Legal Source and should not be taken as legal advice. In fact, none of our site should be taken as legal advice.

Beginning of Jacqueline Boston’s Pradaxa Lawsuit

2012 WL 1834757 (S.D.Ill.) (Trial Pleading)

United States District Court, S.D. Illinois,

East St. Louis Division.

Jacqueline BOSTON, Plaintiff,

v.

BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim Usa Corporation, and Boehringer Ingelheim Vetmedica, Inc., Defendants.

No. 3:12-cv-00610-JPG-SCW.

May 11, 2012.

Jury Trial Demanded

Plaintiff Jacqueline Boston, (herein after “Plaintiff” or “Jacqueline Boston”), by and through Plaintiffs attorneys, brings this action for personal injuries against Defendants Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, and Boehringer Ingelheim Vetmedica, Inc. (collectively, “Boehringer Ingelheim”or “Defendants”). Plaintiff alleges as follows:

PARTIES

At all times relevant hereto, Plaintiff was a resident and citizen of Sparta, Illinois located in Randolph County.

Boehringer Ingelheim Pharmaceuticals, Inc. (“Boehringer”) is a Delaware corporation which has its principal place of business at 900 Ridgebury Road, Ridgefield, Connecticut 06877. Boehringer may be served at CT Corporation System, 208 South LaSalle Street, Suite 814, Chicago, Illinois 60604. Boehringer has conducted business and derived substantial revenue from within the State of Illinois.

Facts of the Boston Pradaxa Lawsuit in Sparta Given

At the start of a court document like the Pradaxa Lawsuit, the party information and facts of the Pradaxa Lawsuit will be given. The Pradaxa Lawsuit of Jacqueline Boston begins in this similar format. You can view the background information of her Pradaxa Lawsuit below.

Background of Jacqueline’s Pradaxa Lawsuit

Pradaxa® is a direct thrombin inhibitor that is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Patients with atrial fibrillation have an increased risk of stroke.

Pradaxa® was approved by the Food and Drug Administration (“FDA”) on October 19, 2010. The FDA approved two dosages: 75 mg and 150 mg, to be taken twice daily. Pradaxa® was the first anticoagulation medication approved in the U.S. in more than 50 years for patients with non-valvular atrial fibrillation.

Prior to the FDA’s approval of Pradaxa®, warfarin was the only oral anticoagulation available in the U.S. for reducing stroke and systemic embolism in patients with atrial fibrillation. Unlike patients who use Pradaxa®, users of warfarin must follow dietary restrictions and regularly monitor their blood levels (INR) by undergoing blood tests and potentially adjusting the dose of their medication.

Charges Against Pradaxa Lawsuit Defendant

The Pradaxa Lawsuit attorney will clearly make their alleged charges against the Pradaxa Lawsuit defendant in the below paragraphs. This first Pradaxa Lawsuit charge involves the over promotion of Pradaxa.

Boehringer Ingelheim Over-promotion leads to Pradaxa Lawsuit

Defendants spent significant money in promoting Pradaxa®, which included $67,000,000.00 spent during 2010 (although Pradaxa® was not approved for sale until October 19, 2010).1

During 2011, Defendants reportedly undertook 1.5 million Pradaxa® “detailing sessions” (marketing/sales visits by Defendants’ sales force) with U.S. primary care physicians, internists, group practitioners, cardiologists, and practice nurses, spending approximately $464,000,000.00 during this 12 month period to promote Pradaxa® in the United States.

As part of their marketing of Pradaxa®, Defendants widely disseminated direct-to-consumer advertising campaigns that were designed to influence patients, including Plaintiff, to make inquiries to their prescribing physician about Pradaxa® and/or request prescriptions for Pradaxa®.

Adverse Events Lead to Pradaxa Lawsuit Filing

Pradaxa Lawsuit movement began as those harmed by Pradaxa sent their reports to the FDA. Within most Pradaxa Lawsuit trial court documents, the statistics below will be given. These numbers strengthen the Pradaxa Lawsuit claim as the drug was only released for a short period of time.

Statistics in Pradaxa Lawsuit for Injuries

From October 2010 until the end of March 2011, approximately 272,119 prescriptions for Pradaxa® were written in the United States. During that same period, there were 932 Pradaxa®-associated “Serious Adverse Event” (“SAE”) Medwatch reports filed with the U.S. Food and Drug Administration, including at least 120 deaths and over 500 reports of severe, life-threatening bleeding.

From April 1 until the end of June 2011, there were an additional 856 Pradaxa®-associated “SAE” Medwatch reports filed with the U.S. Food and Drug Administration including at least 117 deaths and over 510 reports of severe, life-threatening bleeding.

During the Defendants’ 2011 fiscal year, worldwide Pradaxa® sales eclipsed the $1 billion threshold, achieving what is commonly known in the pharmaceutical industry as “blockbuster” sales status.3

As of December 31, 2011, the U.S. Food and Drug Administration received over 500 reports of deaths of people in the U.S. linked to Pradaxa® which, at that point, had been available in the U.S. for approximately 14 months. In addition, there were over 900 reports of gastrointestinal hemorrhages, over 300 reports of rectal hemorrhages, and over 200 reports of cerebrovascular accidents suffered by U.S. citizens associated with Pradaxa®.

Personal Aspects of Jacqueline Boston’s Pradaxa Lawsuit

The personal parts of Jacqueline Boston’s Pradaxa Lawsuit have been included in the Pradaxa Lawsuit excerpt below. You can tell from these reports that she was significantly injured. We have omitted any portion of the Pradaxa Lawsuit which would reveal too much personal information.

Details of Jacqueline’s Injury and Pradaxa Lawsuit Filing

Plaintiff was prescribed Pradaxa® in September, 2011 for treatment of non-valvular atrial fibrillation. Shortly thereafter, Plaintiff suffered a severe gastrointestinal bleed on or about September 27, 2011, causing her to be hospitalized at Memorial Hospital for a period of 12 days. Plaintiff experienced uncontrollable bleeding which was caused and/or worsened by her use of Pradaxa®.

Prior to Plaintiffs use of Pradaxa®, Defendants knew or should have known that the original labeling of the drug did not adequately warn Plaintiff of the risks associated with using the drug as described above.

Prior to Plaintiff’s use of Pradaxa®, Defendants knew or should have known of the defective nature of Pradaxa® and persons who were prescribed and ingested Pradaxa® for even a brief period of time, including the Plaintiff, were at increased risk for developing life-threatening bleeds. Defendants, through their affirmative misrepresentations and omissions, concealed from Plaintiff and Plaintiff’s physicians the true and significant risks associated with Pradaxa® use.

Plaintiff was unaware of the increased risk for developing life-threatening injuries as compared to warfarin. Had Plaintiff and/or Plaintiff’s healthcare provider known of the risks and dangers associated with Pradaxa®, as well as the lack of additional benefits, and had Defendants provided adequate warnings that there is no agent to reverse the anticoagulation effects of Pradaxa®, Plaintiff Jacqueline Boston would not have used Pradaxa®.

As a direct and proximate result of using Pradaxa®, Plaintiff has suffered severe personal injuries, physical pain and mental anguish, including diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications, and fear of developing any of the above named health consequences all resulting from Plaintiffs ingestion of Pradaxa®.

End of Pradaxa Lawsuit Document

Pradaxa Lawsuit Contact Information

You can contact the Best Legal Source team for Pradaxa Lawsuit assistance at (800) 611-7080. Specifically, we help injured people find Pradaxa Lawsuit attorneys who can be trusted to give you experience and a solid work ethic through your Pradaxa Lawsuit process.

Give us a call today at (800) 611-7080 to begin Pradaxa Lawsuit steps!

Pradaxa Lawsuit Resource Page

1-800-611-7080

 

Filed Under: Pradaxa Lawsuit Tagged With: ,

Yaz Lawsuit 400 Million Settlement-807

August 7, 2012 by
Yaz Lawsuit 400 Million Settlement

Yaz Lawsuit 400 Million Settlement

08/07/2012 Yaz Lawsuit 400 Million Settlement: Bayer’s controversial oral contraceptive Yaz has been in the midst of settlement talks for months. The latest update from Bloomberg Businessweek sites the settlements of Yaz Lawsuit claims as rising to $402.6 million. The common trend among those Yaz Lawsuit cases settling are charges of blood clot conditions suffered while on the birth control. Bayer has acknowledged that they have currently paid this large amount for many blood clot cases at the average amount of $212,000 per case.

The number of Yaz Lawsuit and Yasmin Lawsuit cases settled has combined to almost 2,000. The reason for the Yaz Lawsuit against Bayer includes serious blood clot conditions caused by a hormone within both Yaz and Yasmin. The blood clots have been alleged within the Yaz Lawsuit to cause an entire host of problems including strokes, heart attacks and lifelong blood thinning treatments.

The U.S. Food and Drug Administration released safety warnings similar to the claims that are now listed in Yaz Lawsuit trial documents including the risk of pulmonary embolism (PE) and deep vein thrombosis (DVT). These conditions can cause lifelong treatment of blood thinning drugs for those affected. Additionally, a PE or DVT could be life-threatening. The majority of Yaz Lawsuit cases already settled have included plaintiffs who suffered from a PE or DVT. While the settlement phase for Yaz Lawsuit cases as well as Yasmin Lawsuit case are continuing, there is still a narrow window of time to file a new Yaz Lawsuit.

You can contact a Yaz Lawyer concerning future Yaz Lawsuit cases by calling (800) 611-7080. Best Legal Source will put you in the able hands of a Yaz Lawyer that has been screened and is proven to be fair and successful. The process of entering the Yaz Lawsuit does not need to be complicated. Call Best Legal Source for Yaz Lawsuit lawyer assistance today.

Filed Under: Yasmin Lawsuit, Yaz Lawsuit, Yaz Lawyer Tagged With: , ,

Mesothelioma Lawsuit and New Treatments

July 25, 2012 by
Mesothelioma Lawsuit and New Treatments

Mesothelioma Lawsuit and New Treatments

07/25/2012 Mesothelioma Lawsuit and New Treatments: In a press release last week by Bayer HealthCare, it was publicized that a new product to treat Mesothelioma Cancer has been granted the designation of orphan drug. The new drug is a mesothelin-targeting antibody that was given this status by the U.S. Food and Drug Administration. For more information about the orphan drug designation, please visit the FDA site.

This may have no effect on those patients who have filed Mesothelioma Lawsuit cases and are in later stages of their mesothelioma diagnosis; however, it offers a hopeful prospect for those in the early stages of a Mesothelioma Cancer diagnosis.

The drug is known as BAY 94-9343and is in the midst of Phase I clinical trials in Texas, Tennessee and Maryland. The treatment will be for those individuals with advanced solid tumors according to a press release from Bayer. Previously, the prognosis for malignant mesothelioma has been very grim. New developments may fill the void for possible treatment options for Mesothelioma Cancer victims. Mesothelioma generates much legal attention since the direct cause of most all cases is exposure to asbestos fibers located on many job sites.

Mesothelioma Lawsuit cases can be pursued by the person diagnosed with Mesothelioma Cancer or by the family of the victim. Because mesothelioma is caused by direct or indirect exposure to asbestos, the defendant of the Mesothelioma Lawsuit is generally any company responsible for the asbestos exposure. Workers most likely to be exposed include construction workers, plumbers, auto mechanics, navy shipyard employees and electricians among others.

Those searching for legal representation from seasoned Mesothelioma Lawsuit attorneys can call Best Legal Source for prompt assistance. A free consultation with well-known, dependable attorneys involved in Mesothelioma Lawsuit litigation can be obtained on your behalf. Please dial (800) 611-7080 to reach the Best Legal Source helpline.

Filed Under: Mesothelioma Lawsuit Tagged With: ,

Yasmin Lawsuit for Stone

July 25, 2012 by
Yaz Lawsuit for Stone

Yaz Lawsuit for Stone

07/25/2012 Yasmin Lawsuit for Stone: A recent Yasmin Lawsuit challenging the marketing and sales practices of the popular birth control Yaz was added to the large number of Yasmin and Yaz Lawsuit and claims this month. Kristina and Keith Stone filed a Yasmin Lawsuit against defendant Bayer for the questionable practices involved in the manufacturing and marketing of Yasmin. It is not too late to consider filing a Yaz Lawsuit or a Yasmin Lawsuit if you developed blood clotting conditions while taking these birth controls. Contact the Best Legal Source helpline at (800) 611-7080 to begin receiving assistance finding a Yasmin Lawsuit attorney.

Kristina Stone filed as a Yasmin Lawsuit plaintiff against Bayer’s Combined Oral Contraceptives after her three year use of Yasmin from June 2005 to July 2008. As a result of taking this contraceptive, the Yasmin Lawsuit document claims Ms. Stone developed chronic pain, suffering and gall stones that necessitated the removal of her gall bladder. The majority of recent Yaz Lawsuit and Yasmin Lawsuit trial documents state that Bayer had knowledge of their products increased risk to consumers of deep vein thrombosis, pulmonary embolism (both blood clotting conditions), heart attacks and stroke.

Ms. Stone and her husband filed causes of action typical to most Yasmin Lawsuit claims. The reasons for filing include: defective manufacturing, design defects, inadequate warning, negligence, fraud, breaches of warranty, violation of Washington’s Consumer Fraud and Deceptive Business Practices Laws and loss of consortium.

Currently, the Yaz Lawsuit MDL is in the process of settling many of the cases brought against Bayer and will subsequently be reviewing new Yasmin Lawsuit and Yaz Lawsuit cases. It is expected by many legal professionals that the docket and time period for filing Yasmin Lawsuit cases will close soon. If you are weighing your options and considering joining those filing against Bayer, the time to act is now. Please contact the Best Legal Source company at (800) 611-7080 to obtain a consultation with experienced attorneys involved in the Yasmin Lawsuit.

Filed Under: Yasmin Lawsuit, Yaz Lawsuit Tagged With: ,

Nuvaring Lawsuit News

July 20, 2012 by
Nuvaring Lawsuit

Nuvaring Lawsuit

07/20/2012 Nuvaring Lawsuit News: A Nuvaring Lawsuit from the district court of New Jersey was filed earlier this summer by A North Caroline resident against Organon’s birth control product, Nuvaring.

The plaintiff in the Nuvaring Lawsuit is currently a citizen of North Carolina and used the contraceptive Nuvaring from June 20, 2010 to July 8, 2010. On this date, the Plaintiff sustained a severe blood clotting injury known as a deep vein thrombosis.

It is alleged through the Nuvaring Lawsuit that the defendants marketed, promoted and advertised Nuvaring as having less dangerous risk of thrombotic side effects than oral contraceptive pills—all the while knowing that it was less safe than the pill. It is also stated that the defendants failed to warn prescribing physicians and consumers that their product was associated with more thrombotic events than the pill. This is a significant claim since oral pills containing drospirenone are currently involved in settlement phases of legal action known as the Yaz Lawsuit and Yasmin Lawsuit.

The factual statement of the Nuvaring Lawsuit for Ms. Gatling states that Organon knew their product released a continuous stream of hormones (progestin and estrogen) into the body of the user at a higher level than the pill. The defendants failed to release this information and failed to provide that the product released these levels into the blood stream in its promotional literature.

Because of the injuries and statements described above, Ms. Gatling pursued a Nuvaring Lawsuit on the counts of strict product liability, breach of warranty, negligence, fraud, misrepresentation and consumer fraud.

All women who have suffered events similar to Ms. Gatling should be aware that legal opportunities are available to them. A Nuvaring Lawyer may assist you with costly medical bills and ongoing medical costs related to your injury. If you sustained a blood clotting condition while taking Nuvaring, you can contact Best Legal Source at (800) 611-7080 for assistance in finding an attorney active in the Nuvaring Lawsuit case.

Filed Under: Nuvaring Lawsuit Tagged With: